Issue 45, 2019

Vanadyl acetylacetonate attenuates Aβ pathogenesis in APP/PS1 transgenic mice depending on the intervention stage

Abstract

Based on the similar mechanism shared by diabetes mellitus (DM) and Alzheimer's disease (AD), we previously demonstrated that insulin-enhancing vanadyl complexes could preserve cognitive functions in an AD model of APP/PS1 mice after the emergence of β-amyloid (Aβ) plaques. Herein, we further studied the preventive effects of vanadyl complexes. Vanadyl acetylacetonate (VAC) was given to 3-month-old APP/PS1 mice, whose Aβ levels in the brain started to rise with unobservable deposits. Results showed that VAC could ameliorate Aβ pathogenesis in APP/PS1 mice but was less effective than that administrated at 5 months of age. Investigation on the molecular mechanism revealed that compared with vanadium treatment after Aβ plaque formation, earlier VAC administration showed increased clearance of Aβ deposition in the cerebral cortex, however, was much less effective in neuronal protection due to the failure to activate the Grp75 chaperone. These results suggest that neural cells under Aβ burden might exhibit different metabolic patterns and intracellular signal transduction before and after Aβ plaque formation, thus responding differently to vanadyl complexes at different intervention stages. Further studies clarifying the mechanism of the stage-dependent actions of vanadium would be helpful for the rational design of effective anti-AD vanadium agents and better understanding of AD pathogenesis.

Graphical abstract: Vanadyl acetylacetonate attenuates Aβ pathogenesis in APP/PS1 transgenic mice depending on the intervention stage

Article information

Article type
Paper
Submitted
15 fev 2019
Accepted
01 jun 2019
First published
03 jun 2019

New J. Chem., 2019,43, 17588-17594

Vanadyl acetylacetonate attenuates Aβ pathogenesis in APP/PS1 transgenic mice depending on the intervention stage

C. Tan, Y. Dong, J. Wang and X. Yang, New J. Chem., 2019, 43, 17588 DOI: 10.1039/C9NJ00820A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements